Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ / shares in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Expenses:
Consulting (Note 11)	$ 15,000	$ 15,000
Research and development (Note 10)	270	277
Selling, general and administrative (Notes 9 and 13)	46,813	87,637
Loss from operations	(62,083)	(102,914)
Interest income	6	4
Net loss	(62,077)	(102,910)
Other comprehensive loss
Currency translation differences	6,515	(338)
Total comprehensive loss	$ (55,562)	$ (103,248)
Net loss per share - basic and diluted (in dollars per share)	$ (0)	$ (0)
Weighted average number of common shares outstanding – basic and diluted (in shares)	91,422,569	91,422,569